Pharma's biggest losses: Once-dropped drugs make lucrative comebacks
The decision to license or sell a drug depends on profitability, strategic mission, and whether a company “believes” in the science of a drug.
The decision to license or sell a drug depends on profitability, strategic mission, and whether a company “believes” in the science of a drug.
"At most companies we've worked with, the people in upstream functions rarely considered the impact their decisions would have on the front line.
"By getting access to companies' internal emails and nonpublic reports, hackers can use AI to generate very convincing messages."
“Women’s sports enjoy a unique storytelling advantage. They can give audiences the thrill of discovery."
"What I need to do now is to find a road-map that bridges that gap between a functioning democracy and half-baked democracy ... "
Simon Johnson, MIT professor and former IMF chief economist, joins 'Squawk Box' to discuss the banking crisis.
"Technological progress is the most important driver of human flourishing but what we tend to forget is that the process is not automatic."
A recent working paper by Taha Choukhmane found that couples with poor retirement allocations left roughly $700 on the table per year.
"The collapse of Terra in May 2022 marked the first major run in crypto and contributed to the collapse of several other key players."
"I think some of the firms that will be really well positioned going forward are those that really have domain expertise."